Most interestingly, TRMT112 was recently described to form an N6-methyladenosine methyltransferase complex with METTL5, which we also found upregulated in NASH, that remodels fatty acid metabolism and promotes HCC tumorigenesis [84]. The gene discussed is METTL5; the disease is hepatocellular carcinoma.